Key result
Hypertension was significantly associated with a lower overall health-related quality of life score compared to non-hypertensive controls (beta -17.241, p=0.009).
Why the study?
Does hypertension reduce health-related quality of life in Lebanese adults?
Case-Control (n=672)
Yes
Does hypertension reduce health-related quality of life in Lebanese adults?
Hypertension and its treatment burden (frequency of medications, side effects) significantly reduce health-related quality of life in Lebanese adults.
Hypertension was associated with lower HRQoL in Lebanese adults; hypothesis-generating and requires prospective confirmation before guiding care.
Cardiovascular disease is a major cause of morbidity and mortality worldwide, hypertension being one of their most prevalent risk factors. Information on health related quality of life (QOL) of hypertensive individuals in Lebanon is lacking. Our objectives were to evaluate QOL of hypertensive patients compared with non-hypertensive subjects and to suggest possible predictors of QOL in Lebanon. We conducted a case control study among individuals visiting outpatient clinics. Quality of life was assessed using the eight item (SF-8) questionnaire administered face to face to the study population, applied to hypertensive (N=224) and non-hypertensive control (N=448) groups. Hypertensive patients presented lower QOL scores in all domains, particularly in case of high administration frequency and occurrence of drug related side effects. Among hypertensive patients, QOL was significantly decreased with the presence of comorbidities (β=-13.865, p=0.054), daily frequency of antihypertensive medications (β=-8.196, p<0.001), presence of drug side-effects (β=-19.262, p=0.031), older age (β=-0.548, p<0.001), female gender (β=-21.363, p=0.05), lower education (β=-22.949, p=0.006), and cigarettes smoked daily (β=-0.726, p<0.001); regular sport activity (β=23.15, p<0.001) significantly increased quality of life. These findings indicate the necessity for health professionals to take these factors into account when treating hypertensive patients, and to tackle special subgroups with attention to their deteriorated QOL.
No takes yet. Share an insight, caveat, or question.
Khalifeh et al. (2015) conducted a case-control in Hypertension (n=672). Hypertension vs. Non-hypertensive individuals was evaluated on Overall health-related quality of life (QOL) score (beta -17.241, 95% CI -30.166 to -4.317, p=0.009). Hypertension was significantly associated with a lower overall health-related quality of life score compared to non-hypertensive controls (beta -17.241, p=0.009).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: